Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRINITY: Triple Combination Therapy in Hypertension
NCT00649389Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of olmesartan, amlodipine, hydrochlorothiazide in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started May 2008; status: completed.
02
Drugs
olmesartanamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00649389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00649389.